RxDoctor Payments Data

Paul Meyer, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Sioux Falls, SDNPI 1134174865

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.2%), consulting fees and gifts — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AstraZeneca at 40.1% of the total. Reporting peaked in 2024 at $1,607 and has fallen 90.7% since, to $149 in 2025.

$2,619in general payments, 2019–2025

Across 27 payments — averaging $97.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Atricure, Inc.$446
  • Edwards Lifesciences$245
  • American Orthodontics Corporation$169
  • BD$165
  • Abbott$153
  • plus $392 from 5 others
$27,213in research payments, 2019–2025

Across 14 payments — averaging $1943.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$27K

What the payments were for

  • Consulting fees$1,05040%
  • Food & beverage$1,42054%
  • Education$693%
  • Gifts$803%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few thoracic surgery (cardiothoracic vascular surgery) providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$279,420
Medicare patients
329
Services billed
758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →